BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15848465)

  • 1. Excellent liver transplant survival rates under the MELD/PELD system.
    Freeman RB; Harper A; Edwards EB
    Transplant Proc; 2005 Mar; 37(2):585-8. PubMed ID: 15848465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of liver transplant survival rates from the UNOS registry.
    Goh A
    Clin Transpl; 2008; ():19-34. PubMed ID: 19711511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match.
    Avolio AW; Agnes S; Gasbarrini A; Nure E; Siciliano M; Castagneto M
    Transplant Proc; 2006 May; 38(4):1059-62. PubMed ID: 16757263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States.
    Yoo HY; Thuluvath PJ
    Liver Int; 2005 Jun; 25(3):536-41. PubMed ID: 15910490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis.
    Amin MG; Wolf MP; TenBrook JA; Freeman RB; Cheng SJ; Pratt DS; Wong JB
    Liver Transpl; 2004 Dec; 10(12):1468-75. PubMed ID: 15558599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split-liver transplantation in the high-MELD adult patient: are we being too cautious?
    Nadalin S; Schaffer R; Fruehauf N
    Transpl Int; 2009 Jul; 22(7):702-6. PubMed ID: 19254241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the first year of the new liver allocation plan.
    Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
    Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the OPTN/UNOS Liver Transplant Registry.
    Waki K; Tamura S; Sugawara Y; Yamashiki N; Kadowaki T; Kokudo N
    Clin Transpl; 2009; ():55-64. PubMed ID: 20524276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database.
    Bunnapradist S; Chung P; Peng A; Hong A; Chung P; Lee B; Fukami S; Takemoto SK; Singh AK
    Transplantation; 2006 Sep; 82(5):612-8. PubMed ID: 16969282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL; Suchy FJ; Emre S
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
    Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG
    Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The OPTN/UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2005; ():1-16. PubMed ID: 17424721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
    Yao FY; Bass NM; Ascher NL; Roberts JP
    Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.